Morgan Stanley
CEL

Morgan Stanley’s Cellcom Israel, Ltd. CEL Stock Holding History

Morgan Stanley’s Portfolio CEL Stock Details CEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-2,364
Closed -$11K – 7701
2020
Q4 		$11K Sell
2,364
-800
-25% -$3.52K ﹤0.01% 6620
2020
Q3 		$13K Buy
3,164
+2,730
+629% +$10.3K ﹤0.01% 6199
2020
Q2 		$2K Buy
434
+165
+61% +$575 ﹤0.01% 6485
2020
Q1 		$1K Hold
269
– – ﹤0.01% 6526
2019
Q4 		$1K Buy
269
+198
+279% +$537 ﹤0.01% 6618
2019
Q3 		$0 Sell
71
-200
-74% -$518 ﹤0.01% 6862
2019
Q2 		$1K Buy
271
+35
+15% +$135 ﹤0.01% 6606
2019
Q1 		$1K Sell
236
-130
-36% -$627 ﹤0.01% 6560
2018
Q4 		$2K Buy
366
+130
+55% +$849 ﹤0.01% 6457
2018
Q3 		$1K Sell
236
-1,300
-85% -$7.72K ﹤0.01% 6682
2018
Q2 		$9K Sell
1,536
-16
-1% -$109 ﹤0.01% 6337
2018
Q1 		$11K Sell
1,552
-684
-31% -$5.92K ﹤0.01% 6244
2017
Q4 		$23K Hold
2,236
– – ﹤0.01% 6047
2017
Q3 		$21K Sell
2,236
-100
-4% -$917 ﹤0.01% 6016
2017
Q2 		$23K Buy
2,336
+100
+4% +$988 ﹤0.01% 6053
2017
Q1 		$23K Sell
2,236
-10,299
-82% -$106K ﹤0.01% 6047
2016
Q4 		$100K Buy
12,535
+3,499
+39% +$27.2K ﹤0.01% 5574
2016
Q3 		$68K Sell
9,036
-5,523
-38% -$40.2K ﹤0.01% 5466
2016
Q2 		$96K Buy
14,559
+9,823
+207% +$72.7K ﹤0.01% 5259
2016
Q1 		$34K Sell
4,736
-13,261
-74% -$83.8K ﹤0.01% 5753
2015
Q4 		$111K Sell
17,997
-747
-4% -$5.21K ﹤0.01% 5350
2015
Q3 		$116K Buy
18,744
+16,430
+710% +$97.5K ﹤0.01% 5357
2015
Q2 		$8K Sell
2,314
-21,801
-90% -$95K ﹤0.01% 6347
2015
Q1 		$116K Buy
24,115
+6,638
+38% +$38K ﹤0.01% 5474
2014
Q4 		$152K Buy
17,477
+14,707
+531% +$144K ﹤0.01% 5368
2014
Q3 		$31K Sell
2,770
-10,216
-79% -$121K ﹤0.01% 5877
2014
Q2 		$157K Sell
12,986
-4,290
-25% -$56.2K ﹤0.01% 5273
2014
Q1 		$239K Sell
17,276
-34,078
-66% -$439K ﹤0.01% 5033
2013
Q4 		$715K Sell
51,354
-2,105
-4% -$26.7K ﹤0.01% 4202
2013
Q3 		$590K Buy
53,459
+536
+1% +$5.75K ﹤0.01% 4217
2013
Q2 		$489K Buy
+52,923
New +$481K ﹤0.01% 4277

Other funds holding CEL

CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
OSAM
O'Shaughnessy Asset Management Stamford, Connecticut $20.1B AUM 30.42% 1-Year Est. Return
CFG
CKW Financial Group Honolulu, Hawaii $917M AUM 18.41% 1-Year Est. Return
MIH
Meitav Investment House Bene-Beraq, Israel $9.12B AUM 42.07% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
SPIA
Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return

Morgan Stanley's CEL Position: Q1 2021 in Review

Morgan Stanley sold out of Cellcom Israel, Ltd. (CEL) in Q1 2021, closing a stake of 2,364 shares — an estimated $11K sold.

Morgan Stanley first reported a position in CEL in Q2 2013 and held it in 31 quarters. The position peaked at $715K in Q4 2013. 12 funds tracked by Wall St. Rank hold CEL as of Q1 2021.

  • Morgan Stanley reported no remaining Cellcom Israel, Ltd. position as of Q1 2021 after selling out during the quarter.
  • Morgan Stanley sold 2,364 Cellcom Israel, Ltd. shares in Q1 2021, an estimated $11K.
  • Morgan Stanley first reported a position in Cellcom Israel, Ltd. in Q2 2013 and held it in 31 quarters.
  • Morgan Stanley's Cellcom Israel, Ltd. position peaked at $715K in Q4 2013.
  • 12 funds tracked by Wall St. Rank held Cellcom Israel, Ltd. as of Q1 2021.

Based on Morgan Stanley's 13F filing for Q1 2021, filed 17 May 2021.